Guardian Pharmacy Services (NYSE:GRDN) Stock Price Up 5.9% - Should You Buy?

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s share price rose 5.9% during mid-day trading on Thursday . The stock traded as high as $25.47 and last traded at $25.30. Approximately 55,121 shares traded hands during mid-day trading, a decline of 64% from the average daily volume of 155,249 shares. The stock had previously closed at $23.88.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a "buy" rating in a report on Friday, November 15th. Raymond James began coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They issued an "outperform" rating and a $21.00 price objective for the company. Finally, Stephens initiated coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 price target on the stock.

Guardian Pharmacy Services Stock Down 7.6 %

The firm's 50-day simple moving average is $20.63.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. On average, research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Activity at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. bought 35,714 shares of the stock in a transaction on Friday, September 27th. The shares were purchased at an average cost of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now directly owns 35,714 shares of the company's stock, valued at $499,996. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Steven D. Cosler acquired 7,000 shares of the business's stock in a transaction that occurred on Tuesday, November 19th. The stock was bought at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the purchase, the director now directly owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their position. The disclosure for this purchase can be found here.

Institutional Investors Weigh In On Guardian Pharmacy Services

Hedge funds have recently modified their holdings of the business. Stephens Inc. AR bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at $189,000. Virtu Financial LLC acquired a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $279,000. Barclays PLC bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at about $311,000. Point72 DIFC Ltd bought a new stake in shares of Guardian Pharmacy Services during the third quarter worth approximately $573,000. Finally, Royce & Associates LP bought a new position in Guardian Pharmacy Services in the third quarter valued at approximately $1,260,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.